1. Home
  2. SHPH vs AIXI Comparison

SHPH vs AIXI Comparison

Compare SHPH & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shuttle Pharmaceuticals Holdings Inc.

SHPH

Shuttle Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.88

Market Cap

3.1M

Sector

Health Care

ML Signal

HOLD

AIXI

XIAO-I Corporation

HOLD

Current Price

$0.13

Market Cap

2.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHPH
AIXI
Founded
2012
2001
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
2.7M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
SHPH
AIXI
Price
$0.88
$0.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
64.0K
1.2M
Earning Date
05-07-2026
12-31-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$26.84
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.13
52 Week High
$5.59
$4.45

Technical Indicators

Market Signals
Indicator
SHPH
AIXI
Relative Strength Index (RSI) 36.62 23.21
Support Level $0.80 N/A
Resistance Level $2.00 $0.39
Average True Range (ATR) 0.09 0.02
MACD 0.03 -0.01
Stochastic Oscillator 26.92 0.08

Price Performance

Historical Comparison
SHPH
AIXI

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

About AIXI XIAO-I Corporation

XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.

Share on Social Networks: